Dr Emil Bujak
Advisor to HBM Partners
Over ten years of experience in venture capital and medicinal research. Prior experience as a registered pharmacist, and in antibody technology research at Philogen. Holds a PhD and an MSc in Medicinal and Industrial Pharmaceutical Sciences from ETH Zurich and is a Chartered Financial Analyst (CFA) since 2019. Board member of Polyneuron, board observer at Pyxis Oncology.
![Dr Emil Bujak](/sites/default/files/styles/team/public/images/team/bujak.jpg?h=a67c1a76&itok=64CbBusv)